|
|
|
Volumn 13, Issue 1, 1999, Pages
|
|
Nelfinavir, a new protease inhibitor: Early clinical results
|
|
Author keywords
Antiretroviral therapy; Clinical trials; HIV; Nelfinavir; Protease inhibitors
|
|
Indexed keywords
ANTIVIRUS AGENT;
CD4 ANTIGEN;
LAMIVUDINE;
NELFINAVIR;
VIRUS RNA;
ZIDOVUDINE;
CLINICAL TRIAL;
DIARRHEA;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LYMPHOCYTE;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
REVIEW;
VIRUS GENE;
VIRUS MUTANT;
CLINICAL TRIALS;
DISEASE MANAGEMENT;
DRUG INTERACTIONS;
HIV INFECTIONS;
HIV PROTEASE INHIBITORS;
HIV-1;
HUMANS;
NELFINAVIR;
|
|
EID: 0032721763
PISSN: 13502840
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (13)
|
|
References (36)
|
